132 related articles for article (PubMed ID: 15809340)
1. Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.
Takaki T; Fukasawa K; Suzuki-Takahashi I; Semba K; Kitagawa M; Taya Y; Hirai H
J Biochem; 2005 Mar; 137(3):381-6. PubMed ID: 15809340
[TBL] [Abstract][Full Text] [Related]
2. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
Pan W; Cox S; Hoess RH; Grafström RH
Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
[TBL] [Abstract][Full Text] [Related]
3. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
4. Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro.
Takaki T; Fukasawa K; Suzuki-Takahashi I; Hirai H
Biochem Biophys Res Commun; 2004 Mar; 316(1):252-5. PubMed ID: 15003538
[TBL] [Abstract][Full Text] [Related]
5. Catalytic activities of G1 cyclin-dependent kinases and phosphorylation of retinoblastoma protein in mobilized peripheral blood CD34+ hematopoietic progenitor cells.
Leibundgut K; Schmitz NM; Hirt A
Stem Cells; 2005 Aug; 23(7):1002-11. PubMed ID: 15941859
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb.
Li Y; Nichols MA; Shay JW; Xiong Y
Cancer Res; 1994 Dec; 54(23):6078-82. PubMed ID: 7954450
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated phosphorylation site targeted by CDKs.
Zarkowska T; U S; Harlow E; Mittnacht S
Oncogene; 1997 Jan; 14(2):249-54. PubMed ID: 9010227
[TBL] [Abstract][Full Text] [Related]
8. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases.
Zarkowska T; Mittnacht S
J Biol Chem; 1997 May; 272(19):12738-46. PubMed ID: 9139732
[TBL] [Abstract][Full Text] [Related]
9. Docking-dependent regulation of the Rb tumor suppressor protein by Cdk4.
Wallace M; Ball KL
Mol Cell Biol; 2004 Jun; 24(12):5606-19. PubMed ID: 15169919
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of the D-type cyclin-dependent kinases Cdk4 and Cdk6, using a series of monoclonal antibodies.
Lukas C; Jensen SK; Bartkova J; Lukas J; Bartek J
Hybridoma; 1999 Jun; 18(3):225-34. PubMed ID: 10475236
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-linked immunosorbent assay for distinct cyclin-dependent kinase activities using phosphorylation-site-specific anti-pRB monoclonal antibodies.
Suzuki S; Tamai K; Yoshida S
Anal Biochem; 2002 Feb; 301(1):65-74. PubMed ID: 11811968
[TBL] [Abstract][Full Text] [Related]
12. Expression of G1 phase-related cell cycle molecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats.
Kita Y; Masaki T; Funakoshi F; Yoshida S; Tanaka M; Kurokohchi K; Uchida N; Watanabe S; Matsumoto K; Kuriyama S
Int J Oncol; 2004 May; 24(5):1205-11. PubMed ID: 15067343
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A.
Fåhraeus R; Paramio JM; Ball KL; Laín S; Lane DP
Curr Biol; 1996 Jan; 6(1):84-91. PubMed ID: 8805225
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclin-dependent kinase 6, but not cyclin-dependent kinase 4, alters morphology of cultured mouse astrocytes.
Ericson KK; Krull D; Slomiany P; Grossel MJ
Mol Cancer Res; 2003 Jul; 1(9):654-64. PubMed ID: 12861051
[TBL] [Abstract][Full Text] [Related]
15. Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex.
Pan W; Sun T; Hoess R; Grafstrom R
Carcinogenesis; 1998 May; 19(5):765-9. PubMed ID: 9635861
[TBL] [Abstract][Full Text] [Related]
16. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
Guan KL; Jenkins CW; Li Y; Nichols MA; Wu X; O'Keefe CL; Matera AG; Xiong Y
Genes Dev; 1994 Dec; 8(24):2939-52. PubMed ID: 8001816
[TBL] [Abstract][Full Text] [Related]
17. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
Glassford J; Rabin N; Lam EW; Yong KL
Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.
Bockstaele L; Bisteau X; Paternot S; Roger PP
Mol Cell Biol; 2009 Aug; 29(15):4188-200. PubMed ID: 19487459
[TBL] [Abstract][Full Text] [Related]
19. Four distinct cyclin-dependent kinases phosphorylate histone H1 at all of its growth-related phosphorylation sites.
Swank RA; Th'ng JP; Guo XW; Valdez J; Bradbury EM; Gurley LR
Biochemistry; 1997 Nov; 36(45):13761-8. PubMed ID: 9374852
[TBL] [Abstract][Full Text] [Related]
20. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6.
Malumbres M; Sotillo R; Santamaría D; Galán J; Cerezo A; Ortega S; Dubus P; Barbacid M
Cell; 2004 Aug; 118(4):493-504. PubMed ID: 15315761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
